← Back to Search

Healthy Liver/Hígado Sano program for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Led By Natalia I Heredia, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months after enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a program that helps Hispanic/Latino patients with non-alcoholic fatty liver disease (NAFLD) adopt healthier eating and exercise habits to reduce liver fat and improve health.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intervention group participants Satisfaction of program as assessed by the Client Satisfaction Questionnaire (CSQ-8)
Secondary study objectives
Change in Anxiety as assessed by the 7-item Generalized Anxiety Disorder (GAD-7) questionnaire.
Change in Depression as assessed by the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
Change in Perceived treatment efficacy
+12 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Healthy Liver/Hígado Sano programExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Healthy Liver/Hígado Sano program
2022
N/A
~30

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
937 Previous Clinical Trials
337,404 Total Patients Enrolled
3 Trials studying Non-alcoholic Fatty Liver Disease
91 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Prevent Cancer FoundationOTHER
6 Previous Clinical Trials
1,454 Total Patients Enrolled
Natalia I Heredia, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~8 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top